Plain-English translation of NCT06662461 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two different nerve block procedures—both guided by ultrasound—for people with chronic migraines that have not improved with at least two standard migraine medications. One group will receive a block of the greater occipital nerve (located at the back of the head), while the other group will receive a block of the stellate ganglion (a nerve cluster in the neck). Researchers will also measure how these treatments affect a protein called calcitonin gene related peptide, which plays a role in migraines.
Many people with chronic migraines do not respond well enough to standard medications, leaving them with few treatment options. This trial exists to see whether these nerve block procedures can safely and effectively reduce migraine frequency and severity in people whose migraines are resistant to drugs.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of the two nerve block procedures. Both procedures use ultrasound imaging to guide the needle precisely to the nerve site, and both are performed on both sides of your body. After your procedure, you will be monitored and followed up to see how well it works for your migraines and how it affects your migraine-related protein levels. The trial will track your migraine frequency, severity, and quality of life over the study period.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Egypt